What is the appropriate treatment for a skin abscess?

Treatment for Skin Abscess

Incision and drainage (I&D) is the cornerstone of treatment for skin abscesses and is sufficient as monotherapy for most uncomplicated cases in immunocompetent patients. 1, 2

Primary Treatment Algorithm

Step 1: Perform Incision and Drainage

• I&D is the definitive and most important therapeutic intervention for all skin abscesses 1, 2
• For very small furuncles (<3 cm), application of moist heat may promote spontaneous drainage and could be sufficient 1
• Post-procedure, simply cover the surgical site with a dry dressing 1
• Adequate drainage is critical—failing to perform complete I&D is the most common pitfall 1

Step 2: Determine Need for Adjuvant Antibiotics

Add antibiotics to I&D if ANY of the following are present:

Systemic Signs (SIRS Criteria)

• Temperature >38°C or <36°C 1
• Tachycardia >90 beats/minute 1
• Tachypnea >24 breaths/minute 1
• Abnormal white blood cell count 1

High-Risk Patient Factors

• Immunocompromised or markedly impaired host defenses 1, 2
• Significant surrounding cellulitis extending beyond abscess borders 1
• High-risk anatomic locations (face, hands, genitalia) 1
• Incomplete source control after drainage 1

Evidence Supporting Antibiotic Use

• Antibiotics reduce treatment failure from 16.1% to 7.7% (OR 2.32,95% CI 1.75-3.08) 3
• Antibiotics decrease new lesion formation at 1 month (risk difference -10.0%) 3
• Antibiotics lower recurrence within 1 month (OR 0.48) and reduce hospitalization risk (OR 0.55) 4
• However, for uncomplicated abscesses in immunocompetent patients without systemic signs, I&D alone is sufficient 1, 2

Antibiotic Selection When Indicated

First-Line Agents for MRSA Coverage (Community Settings)

Choose TMP-SMX as preferred first-line agent:

• TMP-SMX 1-2 double-strength tablets (160/800 mg) twice daily for adults 5
• Pediatric dosing: 8-12 mg/kg/day divided twice daily 5
• Duration: 5-10 days 1, 5
• Provides similar cure rates to clindamycin (83.1% vs 81.7%, P=0.73) but with fewer adverse events 6

Alternative MRSA-active agents:

• Doxycycline or minocycline 100 mg twice daily (avoid in children <8 years) 1, 5
• Minocycline often superior to doxycycline for CA-MRSA when TMP-SMX fails 5
• Clindamycin 300-450 mg three to four times daily (pediatric: 10-13 mg/kg/dose every 6-8 hours) 1, 5
  • Only use if local MRSA resistance rates are <10% 5
  • Higher risk of gastrointestinal side effects (OR 2.29) and diarrhea (OR 2.71) compared to TMP-SMX 6, 4
  • However, clindamycin reduces new infections at 1 month better than TMP-SMX (6.8% vs 13.5%, P=0.03) 6

Non-MRSA Coverage (When Streptococci Suspected)

• Beta-lactams: penicillinase-resistant penicillins or first-generation cephalosporins 1
• Note: Cephalosporins are probably not effective for MRSA abscesses 4

Severe or Complicated Infections Requiring IV Therapy

• Vancomycin 15-20 mg/kg every 8-12 hours 5
• Linezolid 600 mg IV/PO twice daily 1, 5
• Daptomycin 4-6 mg/kg IV once daily 5
• Ceftaroline 600 mg IV every 12 hours (newer beta-lactam with MRSA activity) 5

Management of Recurrent Abscesses

Immediate Actions

• Obtain cultures early in the course to identify resistant organisms like MRSA 5
• Drain early and aggressively 5
• Rule out underlying structural causes: pilonidal cysts, hidradenitis suppurativa, retained foreign material 5

Decolonization Protocol (5-Day Regimen)

• Intranasal mupirocin twice daily 1, 5
• Daily chlorhexidine body washes 1, 5
• Daily decontamination of personal items 1, 5
• Consider treating household contacts if recurrences persist despite patient decolonization 5

When to Obtain Cultures

Cultures are NOT routinely needed for typical small abscesses but SHOULD be obtained in:

• Recurrent infections 1, 5
• Treatment failures 1
• Immunocompromised patients 1
• Severe or atypical presentations 1

Special Considerations

Abscess Size-Based Approach

• Small abscesses (<3-5 cm): I&D is usually sufficient; antibiotics only if risk factors present 1, 2
• Large abscesses (>5 cm): Consider percutaneous drainage combined with antibiotics 2

Diabetic Patients

• Higher risk of treatment failure 5
• Ensure adequate drainage and consider longer antibiotic courses 5

Critical Pitfalls to Avoid

• Failing to perform adequate I&D—this is the single most important intervention 1, 2
• Not considering MRSA coverage when antibiotics are indicated in high-prevalence areas 1
• Using clindamycin when local MRSA resistance rates exceed 10% 5
• Prescribing antibiotics for simple, uncomplicated abscesses in immunocompetent patients without systemic signs 1, 2
• Delaying drainage while waiting for imaging or laboratory results in clinically stable patients 2
• Overlooking underlying conditions predisposing to recurrent abscesses 1